These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7634114)

  • 21. Generic drug product equivalence: current status.
    Meyer MC
    Am J Manag Care; 1998 Aug; 4(8):1183-9; quiz 1190-2. PubMed ID: 10182892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing interval with albuterol MDI for asthma.
    Reynolds PL
    J Fam Pract; 1997 Dec; 45(6):468. PubMed ID: 9420576
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
    Rajaram L; Roy SK; Skerjanec A
    Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Call for withdrawal of LABA single-therapy inhaler in asthma.
    Beasley R; Perrin K; Weatherall M; Wijesinghe M
    Lancet; 2010 Sep; 376(9743):750-1. PubMed ID: 20816529
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA drug list: key to generic substitution.
    FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
    Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
    Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volmax: simulated gastrointestinal pH and agitation studies.
    Rue PJ; Waterhouse J; Cocchetto DM
    DICP; 1991 Apr; 25(4):438. PubMed ID: 1926921
    [No Abstract]   [Full Text] [Related]  

  • 30. Asthma/Allergy. FDA advises asthma patients to switch to new Albuterol inhalers.
    Child Health Alert; 2008 Sep; 26():5. PubMed ID: 18953699
    [No Abstract]   [Full Text] [Related]  

  • 31. Final count down to hfa albuterol inhalers: are we ready as yet?
    Butt AT; Kamat D; Pansare M
    Clin Pediatr (Phila); 2009 Mar; 48(2):131-4. PubMed ID: 19015282
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
    Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
    Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
    [No Abstract]   [Full Text] [Related]  

  • 34. New insights into the treatment of persistent asthma.
    Checkley W
    Lancet; 2011 Feb; 377(9766):614-6. PubMed ID: 21324521
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products.
    Daley-Yates PT; Parkins DA; Thomas MJ; Gillett B; House KW; Ortega HG
    Clin Ther; 2009 Feb; 31(2):370-85. PubMed ID: 19302910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long acting beta-2 agonists. Discussion of their use in asthma].
    Aumiller J
    MMW Fortschr Med; 2009 Apr; 151(15):14. PubMed ID: 19728671
    [No Abstract]   [Full Text] [Related]  

  • 38. A generic drug primer: regulatory aspects and scientific concepts.
    Henderson JD; White GL
    Mil Med; 1998 Apr; 163(4):193-7. PubMed ID: 9575760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excess mortality in patients with asthma on long-acting beta2-agonists.
    Hasford J; Virchow JC
    Eur Respir J; 2006 Nov; 28(5):900-2. PubMed ID: 17074917
    [No Abstract]   [Full Text] [Related]  

  • 40. Albuterol inhalers.
    Gross NJ
    N Engl J Med; 2007 Jun; 356(26):2749; author reply 2749. PubMed ID: 17596614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.